An Israeli company on Sunday announced a $110 million deal to grow and produce medical cannabis for a European buyer in what it said was the biggest agreement of its kind to be signed in Israel to date.
But it threatened that if the Israeli government did not approve the export of medical cannabis soon, it would sell its knowledge and expertise rather than the cannabis itself.
Medivie Therapeutic and its subsidiary High Pharma will earmark around 100 dunams (25 acres) of land to grow, produce and export up to 50 tons of medical cannabis to the investor each year.
Click here to read the complete article
Sue Surkes ~ TimesOfIsrael.com via 420Intel.com ~
